chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ED NOTE is as follows...from 4/21/21 @ 21:47    a 28 y.o. male who to the emergency room with reports of a headache for the last 48 hours.  He reports this as being one of the worst headaches he has ever had.  He was seen at urgent care and given Toradol, Zofran and Benadryl and still rates his pain an 8 out of 10.  He does feel pressure behind his eyes.  And reports vomiting in the parking lot at urgent care.  He denies abdominal pain back pain, neck pain, shortness of breath, chest pain, numbness or tingling or any other worsening concerns.  Reports that he did receive a recent Johnson & Johnson vaccination.  Patient states he does vape.  He occasionally drinks alcohol he denies any illicit drugs.  Patient denies any head trauma.   Diagnosis management comments: This is a 28-year-old male arrives to the emergency room with reported migraine headache for the last 48 hours.  He did report that he was go to urgent care in which he received a migraine cocktail of Zofran, Benadryl and Toradol.  Patient reported that his headache was not resolved so urgent care sent him on for further evaluation.  Patient upon arrival had a negative neurological exam however he did report that he had pressure behind his eyes.  Was unable to see any papilledema on funduscopic exam.  Check patient's pressures bilaterally and they were 21 and 18.  Patient did report to me that this was the worst headache of his life.  I did administer IV fluids here as well as Tylenol and morphine.  Patient did report some improvement.  Patient did report in his past medical history had a recent Johnson & Johnson vaccination.  A CBC and CMP was obtained.  Did have thrombocytopenia with a count of 66.  Since my exam was PERRL with normal extraocular movements.  He had no eye redness or eye pain.  Of low concerns for any iritis or uveitis.  Patient's patient CT of his head did show a abnormal CT that had a dense appearing superior sagittal sinus that was representing a venous thrombosis.  Radiologist did recommend a MRI MRV.  An MRI and MRV was ordered.  Patient MRI MRv did show findings are consistent with a venous thrombosis involving the right jugular right transverse sinus and superior sagittal sinus there is also a patchy edematous change within the subcortical white matter areas bilaterally and symmetrically.  There was no CVA.  With patient's reported migraine headache.  Reported blurred vision, low platelets, recent vaccination I do believe patient has vaccine induced thrombotic thrombocytopenia.  With this finding I did converse with my overseeing physician Calls were made out to neurology and then a call out did prefer to have patient started on IVIG at 1 g/kg daily for 2 days and blood thinner Xarelto 15 mg p.o. twice daily.  These orders were initiated.  Internal med services was consulted and with conversations of family, internal med services out possible transfer that an interventionalists could be available if patient needed it.  Report was given at 2100 upon my end of shift.
I developed severe hives (angioedema) outbreak that has lasted for months. I am currently taking an antihistamine.
She was actually crying; Very upset; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient. A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CRYING (non-serious), outcome "unknown", described as "She was actually crying"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "Very upset".  Additional information: Caller was very upset that no one will talk to her about the side effects she had after her first dose of the Vaccine. She was actually crying. As I was getting her information to transfer she hung up. Will fax on her behalf. She also did say she was supposed to get the vaccine second dose on May 4th but she did not go.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Admitted for observation ALTE 18 hours after vaccine administration. Episode involved eyes rolling back, limpness, tachypnea, and pale appearance that lasted for a few minutes.  Patient is a 28 week ex premie twin w/ omphalocele, chronic lung disease, and possible gastro-esophageal reflux.5/22/07 Received hospital medical records which reveal patient exterienced fever, viral upper & lower respiratory infection & viral acute gastroenteritis, eyes rolling back, limpness, tachypnea & pallor.  Admitted 5/3-5/7/07.   Experienced respiratory distress, rate & distress & continued diarrhea & was readmitted 5/7-5/10/07.  ID, GI & Pulm consults done.  FINAL DX: 5/3 Viral acute gastroenteritis & viral upper/lower respiratory tract infection.  5/7 Respiratory distress.
Soreness; Pain in the left arm; Headache; Queasy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness), VACCINATION SITE PAIN (Pain in the left arm), HEADACHE (Headache) and NAUSEA (Queasy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced PAIN IN EXTREMITY (Soreness), VACCINATION SITE PAIN (Pain in the left arm), HEADACHE (Headache) and NAUSEA (Queasy). The patient was treated with NAPROXEN SODIUM (ALEVE) for Pain, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Soreness), VACCINATION SITE PAIN (Pain in the left arm), HEADACHE (Headache) and NAUSEA (Queasy) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No relevant concomitant medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow up received by safety 13-Jul-2021 included a significant follow-up: outcome of the events is reported.
Per hospital event reporting system " pt was in with mom for her 4 y.o. well child. Due for her second MMR and vericella, DTAP and IPV. I did my second check with an LPN for verification and all checked out. After administering the vaccines I was in the process of charting the vaccines and realized the MMR was actually a Proquad (MMR/varicella combo)."
I had extreme fatigue, diarrhea, headache, body aches, joint paint, lost of taste, brain fog, confusion, and body heavy. I also don't have much of an appetite and nausea. These symptoms have been going on for almost 11 weeks now. On Jan 3rd, I tested positive for COVID-19. I been to an urgent care and been in contact with my doctor about this.
Developed single hive at injection site of Varicella vaccine - given BENADRYL and observed in office. No respiratory symptoms, no progression of symptoms.
Administered only the liquid component of Menveo; Administered only the liquid component of Menveo; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 15-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number amva768a, expiry date 31-DEC-2023) for prophylaxis.   On 09-JUN-2023, the patient received Menveo. On 09-JUN-2023, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Administered only the liquid component of Menveo) and inappropriate dose of vaccine administered (Verbatim: Administered only the liquid component of Menveo). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 13-JUN-2023 The reporter reported that the patient likely received only liquid component of Menveo due to there being an extra powder component. The reporter did consent to follow up via  The reporter gave by error Menveo liquid portion only ,which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
This spontaneous report as received from a pharmacist refers to a 60 year old female patient. The patient's pertinent medical history was not reported. The patient had no drug reactions or allergies. On 19-DEC-2015, the patient was vaccinated subcutaneously in the right arm with 0.65 ml dose of ZOSTAVAX (lot # L031272, expiry date 19-NOV-2016). Concomitant medications were not reported. On an unknown date in December 2015, the patient experienced infection of the injection site. The patient sought medical attention and came back to the pharmacy and showed the pharmacist the injection site on her right arm. The patient did not go to her family physician at the time of the report. The outcome of the event was unknown. The relatedness between the event and ZOSTAVAX was not reported. This is one of two reports received from the same reporter. Additional information has been requested.
Vomited at 1:15 pm after having vaccine that morning at 9:45am.
I contracted COVID-19 on 08/30/22 with symptoms of congestion, scratchy throat, and fatigue. I was prescribed PAXLOVID on 08/30/22. My symptoms fully resolved after 3 days with no lingering symptoms.
Got up in the morning with swollen, hurting elbow (left arm). Outside of the elbow was reddish, hot and painful. Movement of the arm was limited. Could not support myself with the left arm while sitting at the table as it hurt. I also had some arthritic pains in the joints (wrists, knees and hips) which started a couple days before this. As well as swollen lymph nodes, especially, the one in the left armpit which started 3 days after vaccination and stopped 1 days before the elbow got swollen. Had a phone call with doctor's office where they took the symptoms, but had to wait for 2 days for a video call. During the 2 days the symptoms got slightly better. My doctor suggested it was bursitis, prescribed inflammation reduction medication (ibuprofen) for 3 days and using elbow support for a couple days. After 5 days the elbow was fine. And after several more days other arthritic pains subsided.
I noticed the day after my moderna booster shot which was on my left upper arm that I had a little scratch on my upper left chest.  The following morning  I had a rash on my left breast.  Both of spots I noticed in the morning.
ACUTE ST ELEVATION MI, ANTERIOR WALL ACUTE NON ST ELEVATION MI  11/16/2021 -- RECURRENCE OF SAME SYMPTOMS
Seizure about 10 minutes after receiving first dose of Shingrix vaccine. This was reported today 3/7/20 but vaccine was administered 10/22/19
Patient contracted COVID after being fully vaccinated Runny nose, congestion, cough, fatigue, shortness of breath
This spontaneous report as received from a registered nurse refers to a patient of unknown age. On 09-SEP-2013, the patient ws inadvertently administered GARDASIL (lot number was reported as 0181AA, expiry date was 31-JUL-2013, route and dose were not reported) that had expired on 31-JUL-2013. No adverse effects re ported. Additional information has been requested.
FULL-BLOWN FEVER; TEETH CHATTERING; MILD UNSPECIFIED ADVERSE EVENTS; This spontaneous report received from a patient via a company representative via media article concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: Unk) dose was not reported, 1 total administered on FEB-2021 for prophylactic vaccination (Dose number in series 1). The company is unable to perform follow up to request batch/lot number. No concomitant medications were reported.  On an unspecified date, the patient experienced full-blown fever, and teeth chattering (both events dose number in series 1). The patient reported, J and J knocked her out.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: Unk) dose was not reported, 1 total administered on unspecified date for prophylactic vaccination (Dose number in series 2).  on unspecified date subject experienced mild adverse reaction (Dose number in series 2). Patient also reported that, she felt much milder. "This was like nothing,"  and  within 48 hours she felt completely normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the full-blown fever and teeth chattering was not reported. The outcome of mild adverse reaction was recovered. This report was non-serious.
Patient received a flu shot, after administered, the shot/needle was removed and she bled. It was compressed and bandaged.
Case number PHEH2012US006261 is an initial spontaneous report received from a consumer on 16 Mar 2012. This report refers to a male patient whose age, medical history, past drugs, current conditions and concomitant medications were unspecified. He was vaccinated with H1N1 (manufacturer and batch number unspecified) intramuscularly on an unspecified date. It was reported that he lost his vision in left eye after receiving the vaccine. It was stated that his vision came back, but he experienced blurred vision on hot and humid days. Outcome of the events vision loss was reported as condition improving and that of vision blurred was not provided. No additional details regarding this case were available.
unspecified dose in PROQUAD immunization series were administered after being improperly stored; No symptoms or additional adverse effects reported.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. On 02-JUN-2020, the patient was vaccinated with dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, lot# S022914, expiration date 19-JAN-2021 (strength, dose and route of administration were not reported) reconstituted in properly stored sterile diluent for prophylaxis.  On an unknown date, the dose of the vaccine was exposed to temperature excursion at -14.06 Celsius degrees (C) for 10 minutes. There were previous temperature excursions at -14.28 C for 55 minutes, -13.72 C for 55 minutes and -12.92 C for 5 hours. The call was due to digital data logger. No symptoms or additional adverse effects reported.
Information has been received from a pharmacist concerning a female who was vaccinated with a dose of PNEUMOVAX 23, 0.5ml/IM. Concomitant therapy included tetanus toxoid and influenza virus vaccine (unspecified). Subsequently the patient experienced fever and muscle pain. The patient was initially admitted into the hospital to have a surgery, and then the patient had to stay 2 more days due to the development of the symptoms. At the report time the patient had recovered from fever and muscle pain. Additional information has been requested.
Felt very hot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Felt very hot) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L209) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced FEELING HOT (Felt very hot). At the time of the report, FEELING HOT (Felt very hot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient did not take any treatment medication for the event.   This case was linked to MOD-2021-065798 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow-up received and contains no new information
This spontaneous report has been received from a physician via company representative and refers to a teenage male patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient administered unidentified Merck HPV vaccine (name and lot number not provided) (formulation, strength, dose, and route of administration were not reported). On an unknown date, after receiving the injection, the patient fainted on two different occasions. The physician stated that an ambulance was called to transport the patient to the hospital, but upon arrival the consumer felt better and did not go with the ambulance to the hospital. No product quality complaint was involved. The outcome of fainted on two different occasions was reported as unknown. The relatedness between the event and unidentified Merck HPV vaccine was not reported. Additional information has been requested.
Information has been received from a physician concerning a 21-year-old female who in November 2007, was  vaccinated with a booster dose of MUMPSVAX. It was noted that the patient had two vaccination with MMR II as a child (dates unspecified). Mumps titers were performed and the patient failed to exhibit an immune response > 0.91 for mumps. The patient was seen at the physician's office. No adverse symptoms were reported. A product quality complaint was not involved. Follow-up information was received regarding the 21-year old female white patient (120 pounds, 65 inches) who was vaccinated with a booster dose of MUMPSVAX. The patient received a dose of MMR II on 30-SEP-1988, 11-MAY-1992, and 29-NOV-2007. Laboratory tests on 27-NOV-2007 and 25-APR-2008 showed mumps IgG levels < 0.91. No further information is expected.
Pt recvd 3 doses of Hep B vax given a yr apart & tested neg p/3rd dose;
Pt recv vax on 10/10/93; on 10/20/93 pt exp Guillain-Barre syndrome w/ paresthesia of L1 & L5, nerve root pain x 6 wk
This spontaneous report as received from an office manager refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 06-JUN-2014, the patient was vaccinated with VARIVAX (Merck), 0.5 ml, subcutaneous. Lot number and expiration date were not reported. Other suspect therapies included VAQTA 0.5ml, intramuscular. Lot number J009441, expiration date 23-AUG-2015. On 06-JUN-2014, the patient received improperly stored VARIVAX (Merck) exposed to 15F for 86 hours, and VAQTA exposed to 31F for 86 hours. No adverse event were reported. This is one of several reports from the same source. Additional information has been requested.
Mom states child had sporadic episodes of unusual high pitched cry; Episodes varied in length w/longest being 2hrs; sl elevation in temp of 101; p/2-3 days child was fine;
This case is 1 of a cluster of 2 patients who experienced similar adverse events following vaccination with H1N1. The event for the second patient was captured in case number 2010-02463. Initial report received from a consumer, who was the patient's spouse, on 26 April 2010. A 38-year-old female patient, with no medical history, had received a left arm injection of H1N1 on 10 April 2010 and 1 day later, she developed a fever, phlegm, ear infection, and sore throat which persisted. The patient complained of swollen arm joints and a sore arm in which she was not able to lift the arm. The soreness still remained. The outcome was reported as not recovered. Follow-up information received from a health care professional on 24 May 2010 clarified that, according to the immunization program records, the patient received an intramuscular H1N1, lot number UP100AA, on 30 March 2010 (previously reported by the consumer as 10 April 2010). The patient's facts were inconsistent with the truth and her claim of becoming ill one day after the injection was false. Documents held by sender none.
Pt received COVID vaccine on 4/12/21. Became COVID positive on 4/16/21. Admitted to the hospital on 4/16/21.
Vaccination done on 10/26/2001. Malaise and body aches started on 10/29/2001 afternoon. Fever on 10/29/2001 night. Responded to Motrin. Muscle aches slowly improving, but currently have scratchy throat. No fever in past 4-5 days.
One day after vaccine adm. Pt stated the back of left arm, the site where the varicella vaccine was given, was red, swollen, felt warm to touch and was painful. During the next two days the swelling, pain and redness continued to get worse. This prompted Pt. to visit a local urgent care center for evaluation. Pt was perscribed Keflex for seven days. Pt was not sure of the dosage. Pt stated that all of the antibiotic was taken except for four pills. Pt states the left arm continues to be sore at times.
I became sick the very next day with 2 weeks of severe stomach pains and uncontrollable diarrhea.  My breathing steadily became worse and worse but I didn't make the connection at the time.  My breathing finally became so bad that I went to the hospital on 4-20-22 where they diagnosed me with blood clots in my lungs.  They did a procedure where they threaded wires through my neck into my lungs.  The wire was supposed to break up the clots and to deliver medication.  My breathing has not improved since.
Went to check on patient after 15 minutes and she said she felt slightly  nauseous but did not need any other help. She asked to be discharged to her mother.
pt recvd vax & pt's mom reports pt woke up following AM, unable to raise head d/t large swelling of rt neck, swollen red painful, no malaise, fever, GI sxs, rash or redness;pt seen @ clinic; sl tender neck;
Severe chest pain (left side) for an hour on first time; another sharp pain one week later after the first occurrence Had second dose Aug 6th, haven't got my period by now
Information has been received from a physician concerning a 22 year old female with no pertinent medical history who on 06-APR-2009 was vaccinated with the first dose of GARDASIL (lot # 661953/1130X) and on 09-JUN-2009 received a second dose of GARDASIL (lot # 662404/0312Y) in her left arm. Concomitant therapy included birth control (unspecified). There were no concomitant vaccinations administered with the GARDASIL. On 13-JUN-2009, the patient had motor weakness. She started experienced tingling on her face, left arm, hand, leg and foot. It then progressed to pain and tingling on the entire left side of her body. The patient is left handed. The patient was able to work. The physician reported that the patient was seen by a neurologist who did a magnetic resonance imaging and a magnetic resonance angiography on the patient and the results came back normal. The physician indicated that the patient had not recovered, and the patient had been monitored every day and she could not go on vacation. The patient sought medical attention with her physician. Follow up call information from the neurologist indicated that the patient had left-sided weakness. The patient's magnetic resonance imaging and magnetic resonance angiography were normal. The neurologist stated that as of 29-JUN-2009, there was no definitive diagnosis. The patient would have a repeat magnetic resonance imaging for the next week. Upon internal review, left-sided weakness was determined to be an other important medical event. Additional information has been requested.